A brief review on DNA vaccines in the era of COVID-19
This article provides a brief overview of DNA vaccines. First, the basic DNA vaccine design
strategies are described, then specific issues related to the industrial production of DNA …
strategies are described, then specific issues related to the industrial production of DNA …
Clinical approval of nanotechnology-based SARS-CoV-2 mRNA vaccines: impact on translational nanomedicine
L Milane, M Amiji - Drug delivery and translational research, 2021 - Springer
One year after the first human case of SARS-CoV-2, two nanomedicine-based mRNA
vaccines have been fast-tracked, developed, and have received emergency use …
vaccines have been fast-tracked, developed, and have received emergency use …
Future scenarios for the COVID-19 pandemic
D Skegg, P Gluckman, G Boulton, H Hackmann… - The Lancet, 2021 - thelancet.com
Science has uncovered much about SARS-CoV-2 and made extraordinary and
unprecedented progress on the development of COVID-19 vaccines, but there is still great …
unprecedented progress on the development of COVID-19 vaccines, but there is still great …
COVID-19 vaccine acceptance in the Democratic Republic of Congo: a cross-sectional survey
JD Ditekemena, DM Nkamba, A Mutwadi, HM Mavoko… - Vaccines, 2021 - mdpi.com
We investigated the level of willingness for COVID-19 vaccination in the Democratic
Republic of Congo (DRC). Data were collected between 24 August 2020 and 8 September …
Republic of Congo (DRC). Data were collected between 24 August 2020 and 8 September …
A COVID-19 vaccine: big strides come with big challenges
J Mellet, MS Pepper - Vaccines, 2021 - mdpi.com
As of 8 January 2021, there were 86,749,940 confirmed coronavirus disease 2019 (COVID-
19) cases and 1,890,342 COVID-19-related deaths worldwide, as reported by the World …
19) cases and 1,890,342 COVID-19-related deaths worldwide, as reported by the World …
A summary of the SARS-CoV-2 vaccines and technologies available or under development
ZA Abdulla, SM Al-Bashir, NS Al-Salih, AA Aldamen… - Pathogens, 2021 - mdpi.com
Since the beginning of 2020, the world has been in a race to develop vaccines that can
control the COVID-19 pandemic. More than 250 projects have been initiated for this …
control the COVID-19 pandemic. More than 250 projects have been initiated for this …
Current hurdles to the translation of nanomedicines from bench to the clinic
S Đorđević, MM Gonzalez, I Conejos-Sánchez… - Drug delivery and …, 2022 - Springer
The field of nanomedicine has significantly influenced research areas such as drug delivery,
diagnostics, theranostics, and regenerative medicine; however, the further development of …
diagnostics, theranostics, and regenerative medicine; however, the further development of …
COVID-19 vaccine acceptability and adherence to preventive measures in Somalia: results of an online survey
Most countries are currently gravitating towards vaccination as mainstay strategy to quell
COVID-19 transmission. Between December 2020 and January 2021, we conducted a …
COVID-19 transmission. Between December 2020 and January 2021, we conducted a …
An update review of globally reported SARS-CoV-2 vaccines in preclinical and clinical stages
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of
the rapidly spreading pandemic COVID-19 in the world. As an effective therapeutic strategy …
the rapidly spreading pandemic COVID-19 in the world. As an effective therapeutic strategy …
Neutralizing antibody responses following natural SARS-CoV-2 infection: Dynamics and correlation with commercial serologic tests.
I Montesinos, H Dahma, F Wolff, N Dauby… - Journal of Clinical …, 2021 - Elsevier
The prediction of SARS-CoV-2 immunity by commercially available serologic tests will be
crucial to assess the efficacy of vaccination. We used plaque reduction neutralization testing …
crucial to assess the efficacy of vaccination. We used plaque reduction neutralization testing …